Clinical research in ALS & related disorders for therapeutic development (create)

Ended Cooperative Agreement Awarded Last action

Award ID
U54NS092091
Recipient
Awarding agency
Obligated
$19,449,180

Award facts

Completion date
Originally
Funding
  • $18,476,802.00 Federal
  • $972,378.00 Non-federal
Place of performance
Florida, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $100,000 $0
Amendment $650,000 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $759,301 $0
Amendment $0 $0
Amendment $0 $0
Amendment $768,497 $0
Amendment $768,499 $0
Amendment $768,499 $0
Amendment $768,499 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment -$777,794 $0
Amendment $777,794 $0
Amendment $777,794 $0
Amendment -$777,794 -$777,794
Amendment $777,794 $777,794
Amendment -$777,794 $0
Amendment $777,794 $0
Amendment -$777,794 $0
Amendment $777,794 $777,794
Amendment $777,794 $0
Amendment $777,794 $0
Amendment $777,794 $0
Amendment $194,584 $0
Amendment $194,584 $0
Amendment $194,584 $194,584
Amendment -$788,796 $0
Amendment -$15,263 -$15,263
Amendment $15,263 $15,263
Amendment $15,263 $0
Amendment -$15,263 $0
Amendment $788,796 $0
Amendment -$15,263 $0
Amendment $15,263 $0
Amendment -$788,796 $0
Amendment $13,438 $0
Amendment Clinical research in ALS and related disorders for therapeutic development (create) $788,796 $0
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Subawards

Subrecipient Amount Awarded
ST Jude Children's Research Hospital Inc. Aim 1: Short-read whole genome sequencing and phenotype-genotype correlations for modifiers of ALS and related disorders This study which will be primarily… $588,200
University Of Kansas Medical Center Research Institute, Inc. he PGB study will enroll human subjects affected by ALS, FTD or HSP with identified causative gene mutations and follow them longitudinally to characterize… $47,805
The Trustees Of The University Of Pennsylvania The PGB study will enroll human subjects affected by ALS, FTD or HSP with identified causative gene mutations and follow them longitudinally to characterize the… $57,267
American Brain Foundation Through the creation of public Request for Applications (herein referred to as "RFA"), the parties shall determine appropriately qualified scholars to award a… $50,000
University Of Kansas Medical Center Research Institute, Inc. Project 1 will enroll 200 human subjects affected by ALS, FTD or HSP with identified causative gene mutations and follow them longitudinally to characterize the… $33,480
University Of Cape Town The PGB study will enroll human subjects affected by ALS, FTD or HSP with identified causative gene mutations and follow them longitudinally to characterize the… $77,760
The Trustees Of The University Of Pennsylvania Per Project3, site is responsible for acquiring cross-sectional and longitudinal magnetic resonance imaging (MRI) data from individuals who are first degree… $98,412
ST Jude Children's Research Hospital Inc. Aim 1: Short-read whole genome sequencing and phenotype-genotype correlations for modifiers of ALS and related disorders This study which will be primarily… $265,100
The General Hospital Corporation Eric Macklin, PhD will serve as a Biostatistician at MGH and will devote 1.2 calendar months in years 1-5. He will advise the PI (Dr. Michael Benatar) on issues… $40,121
Mayo Clinic Jacksonville (A Nonprofit Corporation) Dr. Rosa Rademakers is a Professor and Dr. Marka van Blitterswijk is an Assistant Professor in the Department of Neuroscience at Mayo Clinic Jacksonville. Their… $95,368
Mayo Clinic Jacksonville (A Nonprofit Corporation) $183,213
ST Jude Children's Research Hospital Inc. Aim 1: Short-read whole genome sequencing and phenotype-genotype correlations for modifiers of ALS and related disorders This study which will be primarily… $654,442
Show all 12

Quick answers

Who received award U54NS092091?

U54NS092091 was awarded to University Of Miami by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on September 30, 2014.

How much is award U54NS092091 worth?

$19,449,180 has been obligated on U54NS092091: $18,476,802 in federal funding and $972,378 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award